Depression and oxidative stress: Results from a meta-analysis of observational studies

Psychosomatic Medicine

Volumn 76, Issue 1, 2014, Pages 12-19

  Palta, Priya ^a,b,e   Samuel, Laura J ^a   Miller, Edgar R ^a,d   Szanton, Sarah L ^c  

^a JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^b IL   (United States)

^c JOHNS HOPKINS UNIVERSITY SCHOOL OF NURSING   (United States)

^d JOHNS HOPKINS UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF NORTH CAROLINA   (United States)

Author keywords

depression; meta analysis; oxidative stress; review

Indexed keywords

ALBUMIN; ALPHA TOCOPHEROL; ANTIOXIDANT; ASCORBIC ACID; BILIRUBIN; CAROTENOID; CATALASE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; RETINOL; SUPEROXIDE DISMUTASE; URIC ACID;

ARTICLE; BECK DEPRESSION INVENTORY; CENTER FOR EPIDEMIOLOGIC STUDIES DEPRESSION SCALE; DEPRESSION; DSM-IV; EFFECT SIZE; GERIATRIC DEPRESSION SCALE; HAMILTON SCALE; HUMAN; META ANALYSIS; NAMED INVENTORIES, QUESTIONNAIRES AND RATING SCALES; OBSERVATIONAL STUDY; OUTCOME ASSESSMENT; OXIDATIVE STRESS; PATIENT HEALTH QUESTIONAIRE 9; PRIORITY JOURNAL; PROSPECTIVE STUDY; SYSTEMATIC REVIEW; ZUNG SELF RATING DEPRESSION SCALE;

DEPRESSION; META-ANALYSIS; OXIDATIVE STRESS; REVIEW;

DEPRESSION; HUMANS; OBSERVATIONAL STUDY AS TOPIC; OXIDATIVE STRESS;

EID: 84892969101     PISSN: 00333174     EISSN: 15347796     Source Type: Journal    
DOI: 10.1097/PSY.0000000000000009     Document Type: Article

References (35)

1. Cohen S, Janicki-Deverts D, Miller GE. Psychological stress and disease. JAMA 2007;298:1685-7.
2. Rosmond R, Bjorntorp P. The hypothalamic-pituitary-adrenal axis activity as a predictor of cardiovascular disease, type 2 diabetes and stroke. J Intern Med 2000;247:188-97.
3. Rosen P, Nawroth PP, King G, Moller W, Tritschler HJ, Packer L. The role of oxidative stress in the onset and progression of diabetes and its complications: a summary of a Congress Series sponsored by UNESCO-MCBN, the American Diabetes Association and the German Diabetes Society. Diabetes Metab Res Rev 2001;17:189-212.
4. Harrison D, Griendling KK, Landmesser U, Hornig B, Drexler H. Role of oxidative stress in atherosclerosis. Am J Cardiol 2003;91:7AY11A.
5. Semba RD, Ferrucci L, Sun K, Walston J, Varadhan R, Guralnik JM, Fried LP. Oxidative stress is associated with greater mortality in older women living in the community. J Am Geriatr Soc 2007;55:1421-5.
6. Szanton SL, Rifkind JM, Mohanty JG, Miller ER, Thorpe RJ, Nagababu E, Epel ES, Zonderman AB, Evans MK. Racial discrimination is associated with a measure of red blood cell oxidative stress: a potential pathway for racial health disparities. Int J Behav Med 2011;19:489.
7. Michel TM, Pulschen D, Thome J. The role of oxidative stress in depressive disorder. Curr Pharm Des 2012;18:5891.
8. Maes M, Kubera M, Obuchowiczwa E, Goehler L, Brzeszcz J. Depression's multiple comorbidities explained by (neuro)inflammatory and oxidative & nitrosative stress pathways. Neuroendocrinol Lett 2011; 32:7-24.
9. Hovatta I, Juhila J, Donner J. Oxidative stress in anxiety and comorbid disorders. Neurosci Res 2010;68:261-75.
10. Miller ER, Juraschek SP, Appel LJ, Madala M, Anderson CA, Bleys J, Guallar E. The effect of n-3 long-chain polyunsaturated fatty acid supplementation on urine protein excretion and kidney function: meta-analysis of clinical trials. Am J Clin Nutr 2009;89:1937-45.
11. Bilici M, Efe H, Koroglu MA, Uydu HA, Bekaroglu M, Deger O. Antioxidative enzyme activities and lipid peroxidation in major depression: alterations by antidepressant treatments. J Affect Disord 2001;64:43-51.
12. Cumurcu BE, Ozyurt H, Etikan I, Demir S, Karlidag R. Total antioxidant capacity and total oxidant status in patients with major depression: impact of antidepressant treatment. Psychiatry Clin Neurosci 2009;63:639-45.
13. Forlenza MJ, Miller GE. Increased serum levels of 8-hydroxy-2¶- deoxyguanosine in clinical depression. Psychosom Med 2006;68:1-7.
14. Galecki P, Szemraj J, Bienkiewicz M, Florkowski A, Galecka E. Lipid peroxidation and antioxidant protection in patients during acute depressive episodes and in remission after fluoxetine treatment. Pharmacol Rep 2009;61:436-47.
15. Ghodake SR, Suryakar AN, Kulhalli PM, Padalkar RK, Shaikh AK. A study of oxidative stress and influence of antioxidant vitamins supplementation in patients with major depression. Curr Neurobiol 2012;3: 107-11.
16. Herken H, Gurel A, Selek S, Armutcu F, Ozen ME, Bulut M, Kap O, Yumru M, Savas HA, Akyol O. Adenosine deaminase, nitric oxide, su-peroxide dismutase, and xanthine oxidase in patients with major depression: impact of antidepressant treatment. Arch Med Res 2007;38:247-52.
17. Irie M, Miyata M, Kasai H. Depression and possible cancer risk due to oxidative DNA damage. J Psychiatr Res 2005;39:553-60.
18. Khanzode SD, Dakhale GN, Khanzode SS, Saoji A, Palasodkar R. Oxi-dative damage and major depression: the potential antioxidant action of selective serotonin re-uptake inhibitors. Redox Rep 2003;8:365-70.
19. Kotan VO, Sarandol E, Kirhan E, Ozkaya G, Kirli S. Effects of long-term antidepressant treatment on oxidative status in major depressive disorder: a 24-week follow-up study. Prog Neuropsychopharmacol Biol Psychiatry 2011;35:1284-90.
20. Maes M, Mihaylova I, Kubera M, Uytterhoeven M, Vrydags N, Bosmans E. Increased plasma peroxides and serum oxidized low density lipoprotein antibodies in major depression: markers that further explain the higher incidence of neurodegeneration and coronary artery disease. J Affect Disord 2010;125:287-94.
21. Ozcan ME, Gulec M, Ozerol E, Polat R, Akyol O. Antioxidant enzyme activities and oxidative stress in affective disorders. Int Clin Psychopharmacol 2004;19:89-95.
22. Sarandol A, Sarandol E, Eker SS, Erdinc S, Vatansever E, Kirli S. Major depressive disorder is accompanied with oxidative stress: short-term anti-depressant treatment does not alter oxidative-antioxidative systems. Hum Psychopharmacol 2007;22:67-73.
23. Selek S, Dalkilic A, Kaya MC, Savas HA, Bez Y, Celik H, et al. The relationship of oxidative metabolism to treatment response in major depression: a biological basis for treatment duration. Neurology, Psychiatry Brain Res 2012;18:15-8.
24. Selek S, Savas HA, Gergerlioglu HS, Bulbul F, Uz E, Yumru M. The course of nitric oxide and superoxide dismutase during treatment of bipolar depressive episode. J Affect Disord 2008;107:89-94.
25. Srivastava N, Barthwal MK, Dalal PK, Agarwal AK, Nag D, Seth PK, Srimal RC, Dikshit M. A study on nitric oxide, beta-adrenergic receptors and antioxidant status in the polymorphonuclear leukocytes from the patients of depression. J Affect Disord 2002;72:45-52.
26. Yager S, Forlenza MJ, Miller GE. Depression and oxidative damage to lipids. Psychoneuroendocrinology 2010;35:1356-62.
27. Bal N, Acar ST, Yazici A, Yazici K, Tamer L. Altered levels of malondialdehyde and vitamin E in major depressive disorder and generalized anxiety disorder. J Psychol Neurol Sci 2012;25:206-11.
28. Dimopoulos N, Piperi C, Psarra V, Lea RW, Kalofoutis A. Increased plasma levels of 8-iso-PGF2alpha and IL-6 in an elderly population with depression. Psychiatry Res 2008;161:59-66.
29. Kobrosly R, van Wijngaarden E. Associations between immunologic, inflammatory, and oxidative stress markers with severity of depressive symptoms: an analysis of the 2005-2006 National Health and Nutrition Examination Survey. Neurotoxicology 2010;31:126-33.
30. Kupper N, Gidron Y, Winter J, Denollet J. Association between type D personality, depression, and oxidative stress in patients with chronic heart failure. Psychosom Med 2009;71:973-80.
31. Tsuboi H, Shimoi K, Kinae N, Oguni I, Hori R, Kobayashi F. Depressive symptoms are independently correlated with lipid peroxidation in a female population: comparison with vitamins and carotenoids. J Psychosom Res 2004;56:53-8.
32. Wei YC, Zhou FL, He DL, Bai JR, Hui LY, Wang XY, Nan KJ. The level of oxidative stress and the expression of genes involved in DNA-damage signaling pathways in depressive patients with colorectal carcinoma. J Psychosom Res 2009;66:259-66.
33. Zhou F, Zhang W, Wei Y, Zhou D, Su Z, Meng X, Hui L, Tian W. The changes of oxidative stress and human 8-hydroxyguanine glycosylase1 gene expression in depressive patients with acute leukemia. Leuk Res 2007;31:387-93.
34. von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP. The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Epidemiology 2007;18:800-4.
35. Moretti M, Colla A, de Oliveira Balen G, dos Santos DB, Budni D, de Freitas AE, Farina M, Severo Rodrigues AL. Ascorbic acid treatment, similarly to fluoxetine, reverses depressive-like behavior and brain oxi-dative damage induced by chronic unpredictable stress. J Psychiatr Res 2012;46:331-40.